Suchergebnisse - "Krausgruber, Thomas"

PubPharm (74)

61

Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic target

Erschienen: 2013

von Verjee, L. | Verhoekx, J. | Chan, J. | +7

62

PS2-062. Novel role of IRF5 in transcriptional inhibition of human IL-10 gene expression

enthalten in: Cytokine | 2011

von Krausgruber, T. | Saliba, D. | Eames, H. | +4

63

Cytokines and inflammatory mediators: 25. Certolizumab Pegol has a Different Profile from the other Anti-TNFS, Including Golimumab, in a Variety of in Vitro Assays

enthalten in: Rheumatology | 2011

von Nesbitt, A. | Fossati, G. | Whittall, C. | +42

64

IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses

enthalten in: Nature immunology | 2011

von Krausgruber, T. | Blazek, K. | Smallie, T. | +6

65

IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses

enthalten in: Nature immunology | 2011

von Krausgruber, T. | Blazek, K. | Smallie, T. | +6

CommentIn: Nat Rev Immunol. 2011 Feb;11(2):74. - PMID 21467977

66

Beyond the enhanceosome : cluster of novel κB sites downstream of the human IFN-β gene is essential for lipopolysaccharide-induced gene activation

enthalten in: Blood | 2010

von Goh, F. | Thomson, S. | Krausgruber, T. | +3

67

Beyond the enhanceosome: cluster of novel κB sites downstream of the human IFN-β gene is essential for lipopolysaccharide-induced gene activation

enthalten in: Blood | 2010

von Goh, F. | Thomson, S. | Krausgruber, T. | +3

68

SS5-2 IRF5 as a defining factor of M1 macrophage polarization

enthalten in: Cytokine | 2010

von Krausgruber, T. | Saliba, D. | Blazek, K. | +6

69

IRF5 is required for late-phase TNF secretion by human dendritic cells

enthalten in: Blood | 2010

von Krausgruber, T. | Saliba, D. | Ryzhakov, G. | +3

70

IRF5 is required for late-phase TNF secretion by human dendritic cells

enthalten in: Blood | 2010

von Krausgruber, T. | Saliba, D. | Ryzhakov, G. | +3